Eli Lilly and Company (LLY) Stock Overview
NYSE · Healthcare · Drug Manufacturers - General
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Eli Lilly and Company
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200,…
Source: Yahoo Finance
Sector & Industry
Eli Lilly and Company operates in the Healthcare sector, within the Drug Manufacturers - General industry group. It is listed on the NYSE exchange.
Eli Lilly and Company at a Glance
| Company | Eli Lilly and Company |
| Ticker | LLY |
| Exchange | NYSE |
| Currency | USD |
| Price | $1,149.36 |
| Market cap | $1.02T |
| P/E ratio (trailing) | 38.61 |
| EPS (trailing) | $29.77 |
| 52-week high | $1,292.65 |
| 52-week low | $712.05 |
| Dividend yield | 0.60% |
| Ex-dividend date | 14 Aug 2026 |
| Beta | 0.50 |
| Return on equity (ROE) | 102.29% |
| Debt-to-equity | 162.07% |
| Average volume | 2.83M |
| Shares outstanding | 891.74M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Employees | 50,000 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Eli Lilly and Company's current P/E ratio?
- Eli Lilly and Company (LLY) has a trailing P/E ratio of 38.61 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Eli Lilly and Company's market capitalisation?
- Eli Lilly and Company's market cap is $1.02T based on our latest snapshot. See how it ranks by market cap →
- What is LLY's 52-week range?
- Over the past 52 weeks, LLY has traded between $712.05 and $1,292.65. What does the 52-week range mean? →
- How volatile is Eli Lilly and Company compared to the market?
- Eli Lilly and Company has a beta of 0.50, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Eli Lilly and Company pay a dividend?
- Eli Lilly and Company's trailing annual dividend yield is 0.60%. Compare with other high-yield stocks →
- What exchange is LLY listed on?
- LLY is listed on the NYSE. Browse all NYSE-listed stocks →
- What sector is Eli Lilly and Company in?
- Eli Lilly and Company is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →